AtriCure - Stock Price History | ATRC

Historical daily share price chart and data for AtriCure since 2019 adjusted for splits. The latest closing stock price for AtriCure as of December 13, 2019 is 30.49.
  • The all-time high AtriCure stock closing price was 35.58 on September 20, 2018.
  • The AtriCure 52-week high stock price is 33.92, which is 11.2% above the current share price.
  • The AtriCure 52-week low stock price is 22.57, which is 26% below the current share price.
  • The average AtriCure stock price for the last 52 weeks is 29.00.
AtriCure Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 26.1470 18.4700 35.5800 15.0500 30.6000 67.76%
2017 20.3076 19.2000 24.8800 14.9400 18.2400 -6.80%
2016 16.5649 21.1600 21.4700 13.5400 19.5700 -12.79%
2015 21.8535 19.7800 27.9300 17.4000 22.4400 12.42%
2014 17.5247 18.0300 22.1800 13.6400 19.9600 6.85%
2013 10.3316 7.1400 18.9300 7.1400 18.6800 170.72%
2012 8.5684 11.7400 11.9600 5.9100 6.9000 -37.84%
2011 11.4511 10.2500 14.5000 8.5400 11.1000 8.08%
2010 6.7755 5.6500 10.2700 4.5600 10.2700 70.03%
2009 3.2447 2.2000 6.0500 1.0700 6.0400 172.07%
2008 9.7793 13.2400 14.0500 2.0000 2.2200 -83.07%
2007 10.6159 9.1500 13.5900 8.4400 13.1100 46.64%
2006 8.1361 10.7900 11.8000 5.4400 8.9400 -16.06%
2005 13.1674 14.0800 14.9500 10.6500 10.6500 0.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.206B $0.202B
AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as a standard treatment alternative during open-heart surgical procedures to safely, rapidly and reliably create lesions in cardiac, or heart, tissue to block the abnormal electrical impulses that cause atrial fibrillation, a quivering of the upper chambers of the heart.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $152.706B 27.85
Medtronic (MDT) Ireland $152.160B 21.02
Stryker (SYK) United States $75.917B 25.53
Boston Scientific (BSX) United States $62.848B 29.66
Baxter (BAX) United States $42.866B 25.99
Essilor Luxottica (ESLOY) France $34.245B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.456B 19.11
Terumo (TRUMY) Japan $27.092B 0.00
Lonza Group Ag (LZAGY) Switzerland $25.394B 0.00
Coloplast (CLPBY) Denmark $24.797B 38.27
ResMed (RMD) United States $22.090B 40.75
Smith & Nephew SNATS (SNN) United Kingdom $20.228B 0.00
Sunny Optical Technology (SNPTF) China $19.217B 0.00
Insulet (PODD) United States $10.859B 516.62
Bio-Rad Laboratories (BIO) United States $10.615B 50.95
William Demant Holdings (WILYY) Denmark $7.675B 0.00
DiaSorin S.p.A (DSRLF) Italy $7.616B 0.00
Perrigo (PRGO) Ireland $7.340B 13.69
Hill-Rom Holdings (HRC) United States $7.289B 21.49
Canopy Growth (CGC) Canada $7.208B 0.00
Haemonetics (HAE) United States $5.904B 39.89
Shandong Weigao Medical Polymer (SHWGF) China $5.472B 0.00
GN STORE NORD (GNNDY) Denmark $5.276B 0.00
NuVasive (NUVA) United States $3.947B 31.08
ICU Medical (ICUI) United States $3.686B 24.03
Neogen (NEOG) United States $3.583B 59.96
GW Pharmaceuticals (GWPH) United Kingdom $3.293B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.073B 0.00
Quidel (QDEL) United States $2.950B 27.99
Aurora Cannabis (ACB) Canada $2.865B 0.00
Agios Pharmaceuticals (AGIO) United States $2.750B 0.00
National Vision Holdings (EYE) United States $2.495B 56.30
Cardiovascular Systems (CSII) United States $1.607B 0.00
Aphria (APHA) $1.384B 0.00
InMode (INMD) Israel $1.242B 0.00
VAREX IMAGING (VREX) United States $1.199B 24.01
TG Therapeutics (TGTX) United States $1.006B 0.00
Phibro Animal Health (PAHC) United States $0.969B 18.14
NanoString Technologies (NSTG) United States $0.912B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.820B 31.41
Lantheus Holdings (LNTH) United States $0.795B 19.86
LeMaitre Vascular (LMAT) United States $0.711B 39.98
PetIQ (PETQ) United States $0.695B 16.96
Quanterix (QTRX) United States $0.676B 0.00
Omeros (OMER) United States $0.667B 0.00
HEXO (HEXO) $0.576B 0.00
Cerus (CERS) United States $0.560B 0.00
Surmodics (SRDX) United States $0.552B 57.38
MacroGenics (MGNX) United States $0.518B 0.00
OraSure Technologies (OSUR) United States $0.497B 29.80
Meridian Bioscience (VIVO) United States $0.413B 14.21
Organigram Holdings (OGI) Canada $0.405B 0.00
Utah Medical Products (UTMD) United States $0.396B 28.68
Owens & Minor (OMI) United States $0.346B 12.81
BioLife Solutions (BLFS) United States $0.320B 130.58
Zynex (ZYXI) United States $0.305B 34.48
Bovie Medical (APYX) United States $0.276B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.274B 0.00
United Health Products (UEEC) United States $0.251B 0.00
Vapotherm (VAPO) United States $0.244B 0.00
Viemed Healthcare (VMD) United States $0.238B 25.08
Repro-Med Systems (KRMD) United States $0.228B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.172B 0.00
Liberty Health Sciences (LHSIF) Canada $0.171B 0.00
Female Health (VERU) United States $0.157B 0.00
Rockwell Medical (RMTI) United States $0.142B 0.00
Cytosorbents (CTSO) United States $0.136B 0.00
Fonar (FONR) United States $0.130B 9.18
MTech Acquisition (KERN) United States $0.128B 0.00
Chimerix (CMRX) United States $0.110B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.093B 0.00
United-Guardian (UG) United States $0.091B 22.93
Chembio Diagnostics (CEMI) United States $0.078B 0.00
Nephros (NEPH) United States $0.066B 0.00
MRI Interventions (MRIC) United States $0.062B 0.00
Surface Oncology (SURF) United States $0.049B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Trinity Biotech (TRIB) Ireland $0.024B 0.00
Senestech (SNES) United States $0.016B 0.00
GUARDION HEALTH (GHSI) United States $0.015B 0.00
Valeritas Holdings (VLRX) United States $0.014B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.012B 0.00
Capricor Therapeutics (CAPR) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00